title: [Pressure-pulsed cortisone therapy in smelling disorders].
abstract: There is lack of a clear strategy in the treatment of smelling disorders with corticoids. We investigated the olfactory function via the validated Threshold-Discrimination-Identification Score (TDI) in patients with sinonasal, post-URTI or idiopathic disorders before and after topic corticoid pressure-pulsed inhalation therapy (compared to systemic corticoid administration). With both forms of therapy 20% of patients showed a clinically relevant increase of their TDI score of 6 points regardless of sex, age or duration of disease. The pressure pulsed inhalation therapy is an efficient, accepted therapeutic option with less side effects.
authors.affiliation: Göktas, Berlin, Geermany. franca.fleiner@charite.de
authors.forename: F
authors.initials: F
authors.lastname: Fleiner
mesh_terms: D003348:Cortisone / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D000857:Olfaction Disorders / Q000188:drug therapy* / Q000503:physiopathology; D012138:Respiratory Therapy / Q000379:methods*
chemical_list: D003348:Cortisone